Your browser doesn't support javascript.
loading
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors.
Jansen, Hanneke; van Oort, Inge M; van Andel, George; Wijsman, Bart P; Pos, Floris J; Hulshof, Maarten C C M; Hulsbergen-van de Kaa, Christina A; van Leenders, Geert J L H; Fütterer, Jurgen J; Somford, Diederink M; Busstra, Martijn B; van Moorselaar, Reindert J A; Kiemeney, Lambertus A; Aben, Katja K H.
Afiliação
  • Jansen H; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. hannekejansen@gmail.com.
  • van Oort IM; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Wijsman BP; Department of Urology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
  • Pos FJ; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Hulshof MCCM; Department of Radiotherapy, Academic Medical Center, Amsterdam, The Netherlands.
  • Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • van Leenders GJLH; Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Busstra MB; Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Moorselaar RJA; Department of Urology, VU University Medical Center, Amsterdam, The Netherlands.
  • Kiemeney LA; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Aben KKH; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Prostate Cancer Prostatic Dis ; 22(2): 337-343, 2019 05.
Article em En | MEDLINE | ID: mdl-30429595
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male País/Região como assunto: Europa Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male País/Região como assunto: Europa Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido